HR 5587
116th Congress
House
Health
Administrative law and regulatory procedures
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Food supply, safety, and labeling
Government studies and investigations
State and local government operations
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Introduced: January 13, 2020
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 23, 2020
Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Jan 13, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 13, 2020
Introduced in House
Plain-English summary
This bill requires the Food and Drug Administration to regulate a hemp-derived cannabidiol (CBD) product as a dietary supplement instead of as a drug. The bill also allows the introduction into interstate commerce of a food with added hemp-derived CBD.
The Department of Agriculture must report on market and regulatory barriers for producers operating under its domestic hemp production program.
What's happening now
Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Committees of jurisdiction
3